InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the detailed record of transactions filed by Barry James Christopher, Chairman & CEO. Officer active across 1 companies, notably NUVASIVE INC. Aggregated, 9 reports have been logged. Total volume traded: €1.7m. The latest transaction was filed on 13 April 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€266,1395,000 shares@ €53.227815.9% of flow
Common Stock
SEC:0001209191-22-024530:0·
€250,1405,000 shares@ €50.02814.9% of flow
Common Stock
SEC:0001209191-22-021639:0·
053,523 shares0
Common Stock
SEC:0001209191-22-015756:0·
029,904 shares0
Common Stock
SEC:0001209191-21-063680·
029,904 shares0
Common Stock
SEC:0001209191-21-063680:0·
€293,3705,000 shares@ €58.67450.7% of flow
Common Stock
SEC:0001209191-21-043720·
€293,3705,000 shares@ €58.67417.5% of flow
Common Stock
SEC:0001209191-21-043720:0·
€285,4135,000 shares@ €57.082649.3% of flow
Common Stock
SEC:0001209191-21-042809·
€285,4135,000 shares@ €57.082617.1% of flow
Common Stock
SEC:0001209191-21-042809:0·
9 of 9 declarations
About Barry James Christopher
James Christopher Barry is the President and CEO of NUVASIVE INC. As the leader of the company, he oversees strategic operations and ensures growth and innovation. NUVASIVE INC. specializes in medical devices. James plays a key role in developing the company's vision and objectives.
